RIPK2 and neoplasm: The GO enrichment analysis results suggested that the mechanism of RIPK2 in tumours may involve I-kappaB kinase/NF-kappaB signalling, ribonucleoprotein granule and ubiquitin-like protein ligase binding (Additional file 1: Fig. S6-C, D and E).